Bibliografía
 

2- Fouster FM, Booker HE. The epilepsy and convulsive disorders. En: Baker AB, Baker LH (eds). Clinical Neurology. Philadelphia. Lippincot Co, 1984: 1-68.

3- Meldrum BS. Anatomy, physiology and pathology of epilepsy.Epilepsy Octet.The Lancet 1990; 336:231-234.

4- Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalografic classification of epileptic seizures. Epilepsia 1981;22:489-501.

5- Commission on Classification and Terminology of the International League Againts Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985; 26:268-278.

6- Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised  classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.

7- Engel J, Jr. Seizures and epilepsy. Contemporary neurology series. Philadelphia. FA Davis Co,1993.

8- Betts T. Pseudoseizures: seizures that are not epilepsy. The Lancet 1990; 336:163-164.

9- Porter RJ. New antiepileptic agents: strategies for drug development. Epilepsy Octet. The Lancet 1990; 336: 423-427.

10- Antiepileptic drugs. Levy RH, Mattson RH, Meldrum BS. New Jersey. Lippincot-Raven Healthcare, 1996: 71-1070.

11- Gastaut H (ed.) Dictionary of Epilepsy. I: Definition. World Health Organization. Geneva, 1973.

12- Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.) Status epilepticus: mechanism of brain damage and treatment. New York. Raven Press 1983. Adv Neurol 34.

13- Meldrum BS, Vigouroux RA, Brierley JB, Systemic factors and epileptic brain damage. Arch. Neurol 1973;29:82-87.

14- Towne AR, Pellock JM, Ko D et al. Determinants of mortality in status epilepticus. Epilepsia 1994;35(1):27-34.

15- Gross-Tsur V,Shinnar S, Convulsive status epilepticus in children. Epilepsia 1994;34 (suppl 1):S12-S20.

16- Shorvon SD.Status epilepticus: its clinical features and treatment in children and adults. Cambrige: Cambrige University Press 1994.

17- Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990;40 (suppl 2) :9-13.

18- DeLorenzo RJ, Pellock JM et al. Status epilepticus in children, adults and the elderly. Epilepsia 1992;32 (suppl 4): S15-S25.

19- Celesia GG. Modern concepts of status epilepticus. JAMA 1976 ;235 : 1571-1574.

20- Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children. Epilepsia 1970;11:187-197.

21- Hauser WA. Status epilepticus: frequency, etiology and neurological sequelae. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds). Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983. Adv Neurol 34:3-14.

22- Aminoff MJ, Simon RR. Status epilepticus: Causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-666.

 23- Ramsay RE. Treatment of status epilepticus. Epilepsia 993;34 (suppl 1) 571:81.

24- Phillips SA, Shanahan RJ. Etiology and mortality of status epilepticus in children. Arch Neurol 1989;46:74-76.

25- Bleck T. Seizures in the Critically ill patient. In: Parrillo JE, Bone RC. Principles of diagnosis and management. St Louis, Missouri. Mosby Year Book 1995;65:1217-1233.

26- Maytal J, Shinnar S, Moshe SL et al. Low morbidity and mortality of status epilepticus i children. Pediatrics 1989;83:323-331.

27- Nouailhat F, Outin HD, Simon N et al. Status eplepticus and serial seizures. En: Care of the Critically ill patient. Tinker J, Zapol WM (eds.). London.Springer-Verlag 1992;60:1003-1028.

28- DeLorenzo RJ, Pellock JM, Towne AR et al. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-325.

29- Lowenstein DH, Alldrege BK. Status epilepticus at a urban public hospital in the 1980s. Neurology 1993;43:483-488.

30- Wasterlain CG, Fujikawa DG, Penix LR et al. Pathophysiological mechanism of brain damage from status epilepticus. Epilepsia 1993;34 (suppl 1):S37-S53.

31- Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;112(4):326-342.

32- Meldrum BS. Metabolic factors during prolonged seizure and their relation to nevre cell death. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.) . Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983. Adv Neurol 34:261-275.

33- Corselli JN, Bruton CJ. Neuropathology of status epilepticus in humans. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.). Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983; Adv Neurol 34:129-139.

34- Holmes GL. Do seizures cause brain damage? Epilepsia 1991;32 (suppl 5):S14-S28.

35- Glaser GH. Medical complications of status epilepticus. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.). Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983; Adv Neurol 34:395-398.

36- Walton NY. Systemic of generalized convulsive status epilepticus. Epilepsia 1993;34 (suppl 1):S54-S58.

37- Fisher SP, Lee J, Zattuchni J, Greenberg J. Disseminated intravascular coagulatio in stauts epilepticus. Tromb Hemostasis1977;38:909-913.

38- Treiman DM. Generalized convulsive status epilepticus in the adult. Epilepsia 1993;34 (suppl 1): S2-S11.

39- Cascino GD. Generalized convulsive status epilepticus. Mayo Clin Proc 1996;71:787-792.

40- Scholtes FB, Renier WO, Meinardi H. Generalized  convulsive status eplepticus: Causes, therapy, and outcome in 346 patients. Epilepsia 1994;35(5):1104-1112.

41- Treiman DM, Walton NY, Kendrick C. A pprogressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.

42- Lowenstein DH, Aminoff MJ. Clinical and EEG features of status epilepticus in comatose patients. Neurology 1992;42:100-104.

43- Dodrill CB, Wilensky AJ. Intellectual impairment as a outcome of status epilepticus. Neurology 1990;40 (suppl 2):23-27.

44- Gastaut H. Classification of status epilepticus. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.). Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983. Adv Neurol 34:15-32.

45- Rawal K,  D’Souza BJ. Status epilepticus. Crit Care Clin 1985;1:339-353.

46- Lennox WG, Lennox Ma(eds). Epilepsy and rlated disorders. Boston. Little Brown and Co 1960.

47- Dreifus FE. Juvenile myoclonc epilepsy: Characteristics of a primary generalized epilepsy. Epilepsia 1989;30 (suppl 4): S1-S7.

48- Berkovic SF, Andermann F, Carpenter S et al. Progressive myoclonus epilepsies: Specific caues and diagnosis. N Engl J Med 1986;315:296-305.

49- Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781-784.

50- Jumao-as A, Brenner RP. Myoclonic status epilepticus: A clinical and electroencephalographic study. Neurology 1990;40:1199-1202.

51- Oller i Daurella LL, Oller i Ferrer-Vidal LL. L’epilèpsia. Monografies Mèdiques 18. Acadèmia de Ciències Mèdiques de Catalunya i de Balears. Barcelona 1979.

52-Cascino GD. Nonconvulsive status epilepticus in adults and children. Epilepsia 1993;34 (suppl 1): S21-S28.

 53-Tomson T, Lindbom U, Nilsson BY. Nonconvulsive status epilepticus in adults: Thirty-two consecutive patients from a General Hospital population. Epilepsia 1992;33(5):829-835.

54- Granner MA, Lee SI. Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 1994;(1):42-47.

55- Thomas P, Beaumanoir A, Genton P et al. “De novo” absence status of the late onset. Report of 11 cases. Neurology 1992;42:104-110.

56- Kaplan PW. Nonconvulsice status epilepticus in the Emergency Room. Epilepsia 1996;37(7):643-650.

57- Passouant P, Cadilhac J, Rinstein M et al. Les états de mal partiels. En: GastaujH, Roger J, Lob H (eds.). Les états de mal epileptiques. Paris. Masson 1967:152-181.

58- Scholtes FB, Renier WO, Meniardi H. Simple partial sttus epilepticus: Causes, treatment and outcome in 47 patiens. J Neurol Neurosurg Psychiatry 1996;61:90-92.

59-Schomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia 1993;34(suppl 1):S29-S36.

60- Cockerell OC, Rothwell J, Thompson PD et al. Clínical and physiological features of epilepsia partialis continua. Brain 1996;119:393-407.

61- Treiman DM, Delgado-Escuta AV. Complex partial status epilepticus. En: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds.). Status epilepticus: Mechanism of brain damage and treatment. New York. Raven Press 1983. Adv Neurol 34:69-81.

62- Krumholz A, Sung GY, Fisher RS et al. Complex partial status epilepticus acompaned by serioous morbidity and mortality. Neurology 1995;45:1499-1504.

63- Gastaut H, Vigourous M, Trevisan C et al. Le syndrome hemiconvulsions-hémiplegie-épilepsie (sydrome HHE). Rev Neurol (Paris) 1957;97:37-52.

64- Shorvon S. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry 1993;56:125-134.

65- Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993;22:1337-1348.

66- Delgado-Escueta AV, Wastrlain C, Treiman DM et al. Management of status epilepticus. N Engl J Med 1982;306:1337-1340.

67- Focadas I, Beristain X, Lasa A et al. Avances en el tratamiento del estado de mal epiléptico. En: Neurología Crítica. Net A, Marruecos L (eds.). Barcelona. Springer-Verlag Ibérica 1996:339-358.

68- Bleck TP, Stefan H. Status epilepticus. En: Hacke W (ed.). Neuro Critical Care. Berlin, Heildelberg. Springer-Verlag 1994;66:761-769.

69- Mitchell WG. Status epilepticus and acute repetitive seizures. Epilepsia  1996;37 (suppl 1): S74-S80.

70- Bone RC (ed.). Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA 1993;270:854-859.

71- Treiman DM. Pharmacokinetics and clnical use of benzodiazepines in the management of status epilepticus.  Epilepsia 1989;30 (suppl 2):S4-S-10.

72- Mattson RH. Parenteral antiepileptic anticonvulsant drugs. Neurology 1996;46 (supll 1):S8-S13.

73-Ramsay RE, DeToledo J. Intravenous administration of fosfophenytoin: Optims for the management of seizures. Neurology 1996;46 (suppl 1):S17-S19.

74- Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continous infusion of midazolam. Neurology 1994;44:1837-1840.

75- Pascual J, Ciudad J, Berciano J. Role of lidocaine (lignocaine) in managing status epilepticus. J Neurol Neurosurg Psychiatry 1992;55:49-51.

76- Van Ness PC. Pentobarbital and EEg burst supression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990;31(1):61-67.

77- Yaffe K, Lowenstein DH. Prognostic factors of pentobarbital therapy for refractory generalizaed status epilepticus. Neurology 1993;43:895-900.

78- Borgeat A, Wilder-Smith OHG, Jallon P et al. Propofol in the management of refractory status epilepticus: a case report. Intensive Care Med 1994;20:148-149.

79- Kuisma M, Roine RO. Propofol in prehospital treatment of convulsive status epilepticus. Epilepsia 1995;(12):1241-1243.

80- Kofke WA, Young RSK, Davis P et al. Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology 1989;71:653-659.

81- Yeoman P Hutchinson A, Bryne A et al. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med 1989;15:255-259.

82- Britton JW, So EL. Selection of antiepileptic drugs: A practical approach. Mayo Clin Proc 1996;71:778-786.

83- Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996;18:168-175.

84- Marruecos L, Paniagua-Soto J. El EG en patología neurològica aguda. En: Net A, Marruecos L (eds.). Neurologìa Clínica. Barcelona. Springer-Verlag Ibérica 1994:15-25.